NO920523L - Ige-reseptor-antistoff - Google Patents

Ige-reseptor-antistoff

Info

Publication number
NO920523L
NO920523L NO92920523A NO920523A NO920523L NO 920523 L NO920523 L NO 920523L NO 92920523 A NO92920523 A NO 92920523A NO 920523 A NO920523 A NO 920523A NO 920523 L NO920523 L NO 920523L
Authority
NO
Norway
Prior art keywords
ige
receptor antibody
antibody
receptor
Prior art date
Application number
NO92920523A
Other languages
English (en)
Norwegian (no)
Other versions
NO920523D0 (no
Inventor
Richard Anthony Chizzonite
John Hakimi
Jarema Peter Kochan
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO920523D0 publication Critical patent/NO920523D0/no
Publication of NO920523L publication Critical patent/NO920523L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO92920523A 1991-02-11 1992-02-10 Ige-reseptor-antistoff NO920523L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65393691A 1991-02-11 1991-02-11

Publications (2)

Publication Number Publication Date
NO920523D0 NO920523D0 (no) 1992-02-10
NO920523L true NO920523L (no) 1992-08-12

Family

ID=24622869

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92920523A NO920523L (no) 1991-02-11 1992-02-10 Ige-reseptor-antistoff

Country Status (20)

Country Link
EP (1) EP0499112A1 (ja)
JP (1) JPH05252988A (ja)
KR (1) KR920016105A (ja)
AR (1) AR245784A1 (ja)
AU (1) AU652024B2 (ja)
BR (1) BR9200442A (ja)
CA (1) CA2059842A1 (ja)
CS (1) CS39092A3 (ja)
FI (1) FI920565A (ja)
HU (1) HUT63205A (ja)
IE (1) IE920434A1 (ja)
IL (1) IL100869A0 (ja)
IS (1) IS3813A (ja)
MX (1) MX9200526A (ja)
NO (1) NO920523L (ja)
NZ (1) NZ241552A (ja)
RO (1) RO109707B1 (ja)
UY (1) UY23374A1 (ja)
YU (1) YU13392A (ja)
ZA (1) ZA92800B (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770396A (en) * 1992-04-16 1998-06-23 The United States Of America As Represented By The Department Of Health And Human Services Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E
ATE157455T1 (de) * 1993-12-10 1997-09-15 Genentech Inc Methoden zur diagnose von allergie und prüfung anti-allergischer therapeutika
US7135458B1 (en) 1995-11-15 2006-11-14 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Interferon-γ inducing polypeptide, pharmaceutical composition thereof, monoclonal antibody thereto, and methods of use
JP2952750B2 (ja) * 1995-02-23 1999-09-27 株式会社林原生物化学研究所 モノクローナル抗体
US6423512B1 (en) 1996-07-26 2002-07-23 Novartis Ag Fusion polypeptides
PE99498A1 (es) * 1996-07-26 1999-01-21 Novartis Ag Polipeptidos de fusion
US6299875B1 (en) 1998-06-04 2001-10-09 Panacea Pharmaceuticals, Llc Methods to block IGE binding to cell surface receptors of mast cells
US7759133B2 (en) * 1998-12-22 2010-07-20 Alk-Abello A/S Method of detecting and/or quantifying a specific IgE antibody in a liquid sample
EP1269198A2 (en) * 2000-03-23 2003-01-02 Novartis AG Identification of mast/basophil activation inhibitors
US7384633B2 (en) 2001-07-19 2008-06-10 Judicial Foundation The Chemo-Sero-Therapeutic Res. Human type antihuman IgE receptor antibody and fragment
NZ577858A (en) * 2007-01-29 2012-02-24 Valtion Teknillinen Method for producing novel ige based reagents
KR101686395B1 (ko) 2015-06-22 2016-12-15 주식회사 선일기연 Ｐｃｂ용 단자 삽입기의 삽입력 측정장치
CN105352930A (zh) * 2015-12-01 2016-02-24 深圳市绿诗源生物技术有限公司 基于amf为荧光素标记物的双酚a荧光偏振免疫分析检测方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962035A (en) * 1987-12-01 1990-10-09 President And Fellows Of Harvard College DNA encoding IgE receptor alpha-subunit or fragment thereof

Also Published As

Publication number Publication date
JPH05252988A (ja) 1993-10-05
EP0499112A1 (en) 1992-08-19
YU13392A (sh) 1995-01-31
NZ241552A (en) 1994-03-25
MX9200526A (es) 1992-08-01
IE920434A1 (en) 1992-08-12
KR920016105A (ko) 1992-09-24
UY23374A1 (es) 1992-07-30
CS39092A3 (en) 1992-09-16
FI920565A0 (fi) 1992-02-11
ZA92800B (en) 1992-10-28
BR9200442A (pt) 1992-10-20
IS3813A (is) 1992-08-12
HUT63205A (en) 1993-07-28
AU652024B2 (en) 1994-08-11
AU1080292A (en) 1992-08-13
NO920523D0 (no) 1992-02-10
AR245784A1 (es) 1994-02-28
CA2059842A1 (en) 1992-08-12
FI920565A (fi) 1992-08-12
HU9200293D0 (en) 1992-04-28
RO109707B1 (ro) 1995-05-30
IL100869A0 (en) 1992-11-15

Similar Documents

Publication Publication Date Title
DE69225757T2 (de) Lyophilische monoklonale antikörperpräparationen
DK145493D0 (da) Antistof
DK666389A (da) Monoklonalt antistof
DE69232604T2 (de) Antikörperkonstrukte
CY2006001I2 (el) Ανθρωποποιημενο heregulin αντισωμα
DK0574782T3 (da) Dobbeltanalyt-immunassay
DE68914244T2 (de) Monoklonaler Antikörper.
NO920523L (no) Ige-reseptor-antistoff
EP0580859A4 (en) Anti-eda monoclonal antibody
DE59307768D1 (de) Schiebeelement
DE69334135D1 (de) Kopiergerät
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DE69223606T2 (de) Humaner monoklonaler antikörper gegen glycoprotein-iib/iiia
FI934447A0 (fi) Nytt immunhaemmande aemne fraon strptomyces braegensis
DK474189A (da) Monoklonalt antistof
ITMI910491A0 (it) Immonotossina da anticorpi monoclonali anti-cds
DE68912772T2 (de) Monoklonaler antikörper gegen entero-viren.
DK413389D0 (da) Monoklonale antistoffer
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
DE59307896D1 (de) Kopiervorrichtung
FI925638A0 (fi) Monoklonal antikropp 88bv59 riktad mot en i samband med tumoerer foerekommande antigen
DE69324928T2 (de) Monoklonaler antikörper
SE9002479D0 (sv) Antibody conjugates
DE68916088T2 (de) Anti-CPBII-monoklonaler Antikörper.
SE9200338D0 (sv) Antikroppssubstans